Literature DB >> 33868276

Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis In Vivo.

George Adigbli1, Peng Hua2,3, Masateru Uchiyama1, Irene Roberts2,4, Joanna Hester1, Suzanne M Watt3,5, Fadi Issa1.   

Abstract

Humanized immune system (HIS) mouse models are useful tools for the in vivo investigation of human hematopoiesis. However, the majority of HIS models currently in use are biased towards lymphocyte development and fail to support long-term multilineage leucocytes and erythrocytes. Those that achieve successful multilineage reconstitution often require preconditioning steps which are expensive, cause animal morbidity, are technically demanding, and poorly reproducible. In this study, we address this challenge by using HSPC-NBSGW mice, in which NOD,B6.SCID IL-2rγ -/-KitW41/W41 (NBSGW) mice are engrafted with human CD133+ hematopoietic stem and progenitor cells (HSPCs) without the need for preconditioning by sublethal irradiation. These HSPCs are enriched in long-term hematopoietic stem cells (LT-HSCs), while NBSGW mice are permissive to human hematopoietic stem cell (HSC) engraftment, thus reducing the cell number required for successful HIS development. B cells reconstitute with the greatest efficiency, including mature B cells capable of class-switching following allogeneic stimulation and, within lymphoid organs and peripheral blood, T cells at a spectrum of stages of maturation. In the thymus, human thymocytes are identified at all major stages of development. Phenotypically distinct subsets of myeloid cells, including dendritic cells and mature monocytes, engraft to a variable degree in the bone marrow and spleen, and circulate in peripheral blood. Finally, we observe human erythrocytes which persist in the periphery at high levels following macrophage clearance. The HSPC-NBSGW model therefore provides a useful platform for the study of human hematological and immunological processes and pathologies.
Copyright © 2021 Adigbli, Hua, Uchiyama, Roberts, Hester, Watt and Issa.

Entities:  

Keywords:  genome editing; human hematological reconstitution in vivo; human immune system mice; immune reconstitution; non-irradiation; red blood cell reconstitution

Mesh:

Year:  2021        PMID: 33868276      PMCID: PMC8044770          DOI: 10.3389/fimmu.2021.642198

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  52 in total

1.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.

Authors:  S Miraglia; W Godfrey; A H Yin; K Atkins; R Warnke; J T Holden; R A Bray; E K Waller; D W Buck
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

2.  B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production.

Authors:  K Agematsu; H Nagumo; F C Yang; T Nakazawa; K Fukushima; S Ito; K Sugita; T Mori; T Kobata; C Morimoto; A Komiyama
Journal:  Eur J Immunol       Date:  1997-08       Impact factor: 5.532

Review 3.  Humanized hemato-lymphoid system mice.

Authors:  Alexandre P A Theocharides; Anthony Rongvaux; Kristin Fritsch; Richard A Flavell; Markus G Manz
Journal:  Haematologica       Date:  2016-01       Impact factor: 9.941

4.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.

Authors:  Satish N Nadig; Joanna Wieckiewicz; Douglas C Wu; Gregor Warnecke; Wei Zhang; Shiqiao Luo; Alexandru Schiopu; David P Taggart; Kathryn J Wood
Journal:  Nat Med       Date:  2010-05-16       Impact factor: 53.440

6.  Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.

Authors:  Brian E McIntosh; Matthew E Brown; Bret M Duffin; John P Maufort; David T Vereide; Igor I Slukvin; James A Thomson
Journal:  Stem Cell Reports       Date:  2015-01-15       Impact factor: 7.765

7.  Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3.

Authors:  Sonal Jangalwe; Leonard D Shultz; Anuja Mathew; Michael A Brehm
Journal:  Immun Inflamm Dis       Date:  2016-08-28

8.  Improved multilineage human hematopoietic reconstitution and function in NSGS mice.

Authors:  Mark Wunderlich; Fu-Sheng Chou; Christina Sexton; Pietro Presicce; Claire A Chougnet; Julio Aliberti; James C Mulloy
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

9.  Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo.

Authors:  Fadi Issa; Kate Milward; Ryoichi Goto; Gareth Betts; Kathryn J Wood; Joanna Hester
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

10.  The relationship between CD27 negative and positive B cell populations in human peripheral blood.

Authors:  Yu-Chang Bryan Wu; David Kipling; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2011-12-26       Impact factor: 7.561

View more
  3 in total

Review 1.  Stem Cell-Based Disease Models for Inborn Errors of Immunity.

Authors:  Aline Zbinden; Kirsten Canté-Barrett; Karin Pike-Overzet; Frank J T Staal
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 2.  Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates.

Authors:  Magdalena Cybula; Magdalena Bieniasz
Journal:  Oncotarget       Date:  2022-03-24

Review 3.  Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging.

Authors:  Suzanne M Watt; Peng Hua; Irene Roberts
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.